People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ImmPACT Bio USA Inc. | — | Biotechnology | Series D+ | $143.6M | $3.5B | 2022 |
Yvonne Yu-Hsuan Chen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yvonne Yu-Hsuan Chen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Asish Xavier | 1 | 18 |
| Michal Silverberg | 1 | 7 |
| Erez Chimovits | 1 | 7 |
| Cindy Xiong | 1 | 2 |
| Yvonne Yamanaka | 1 | 2 |
| Richard Kendall | 1 | 2 |
| Assaf Keret | 1 | 1 |
| David Zigdon | 1 | 1 |
| Robbie Woodman | 1 | 1 |
| Han Yu-Hsuan Lee | 1 | 1 |
| Xiangmin Yu-Hsuan Cui | 1 | 1 |
| Sheila Yu-Hsuan Guirathi | 1 | 1 |
| Sumant Ramachandra | 1 | 1 |
| Anat Yu-Hsuan Nursella | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.